Skip to main content

Table 1 Patients treated with ECMO for respiratory failure.

From: Extracorporeal life support for management of refractory cardiac or respiratory failure: initial experience in a tertiary centre

Patients

Age/Gender

SAPS II at admission

Indication

Time to ECMO from ARDS diagnosis (days)

Hours of critical hypoxia (PaO2/FiO2 < 60) and/or critical acidosis (pH < 7.20)

ECMO duration (hours)

ECMO-related complications

ICU LOS (days)

ICU outcome

Pt 1

70/M

27

ARDS

(infective)

12

4

269

Local bleeding

33

Survived

Pt 2

19/M

47

ARDS

(post-traumatic)

1

4

33

None

3

Non survived

Pt 3

64/F

62

ARDS

(infective)

1

2

44

Intracranial bleeding

3

Non survived

Pt 4

65/M

58

ARDS

(post-traumatic)

1

1

231

Local bleeding

65

Survived

Pt 5

69/M

29

ARDS

(infective)

1

5

264

Local bleeding

20

Survived

Pt 6

67/M

82

ARDS

(infective)

10

8

253

Local bleeding

12

Non survived

Pt 7

59/M

50

ARDS

(infective)

4

8

626

Oxygenator failure

27

Non survived

Pt 8

61/M

62

ARDS

(infective)

5

5

330

None

15

Non survived

Pt 9

15/M

66

ARDS

(H1N1)

0

5

137

None

17

Survived

Pt 10

58/M

24

ARDS

(H1N1)

2

4

154

None

13

Survived

Pt 11

44/F

46

Viral acute lung failure

(H1N1)

2

5

374

Local bleeding

20

Survived

Pt 12

48/M

40

ARDS

(H1N1)

1

6

184

Local bleeding

17

Survived

Pt 13

30/M

44

Viral acute lung failure

(H1N1)

1

6

151

None

18

Survived